These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32023463)

  • 21. Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG.
    Anastas JN; Zee BM; Kalin JH; Kim M; Guo R; Alexandrescu S; Blanco MA; Giera S; Gillespie SM; Das J; Wu M; Nocco S; Bonal DM; Nguyen QD; Suva ML; Bernstein BE; Alani R; Golub TR; Cole PA; Filbin MG; Shi Y
    Cancer Cell; 2019 Nov; 36(5):528-544.e10. PubMed ID: 31631026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ash2l interacts with Oct4-stemness circuitry to promote super-enhancer-driven pluripotency network.
    Tsai PH; Chien Y; Wang ML; Hsu CH; Laurent B; Chou SJ; Chang WC; Chien CS; Li HY; Lee HC; Huo TI; Hung JH; Chen CH; Chiou SH
    Nucleic Acids Res; 2019 Nov; 47(19):10115-10133. PubMed ID: 31555818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancer decommissioning by LSD1 during embryonic stem cell differentiation.
    Whyte WA; Bilodeau S; Orlando DA; Hoke HA; Frampton GM; Foster CT; Cowley SM; Young RA
    Nature; 2012 Feb; 482(7384):221-5. PubMed ID: 22297846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The regulatory role of histone deacetylase inhibitors in Fgf4 expression is dependent on the differentiation state of pluripotent stem cells.
    Shi G; Gao F; Jin Y
    J Cell Physiol; 2011 Dec; 226(12):3190-6. PubMed ID: 21321941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reorganization of enhancer patterns in transition from naive to primed pluripotency.
    Buecker C; Srinivasan R; Wu Z; Calo E; Acampora D; Faial T; Simeone A; Tan M; Swigut T; Wysocka J
    Cell Stem Cell; 2014 Jun; 14(6):838-53. PubMed ID: 24905168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone demethylase LSD1-mediated repression of GATA-2 is critical for erythroid differentiation.
    Guo Y; Fu X; Jin Y; Sun J; Liu Y; Huo B; Li X; Hu X
    Drug Des Devel Ther; 2015; 9():3153-62. PubMed ID: 26124638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PRDM14 Drives OCT3/4 Recruitment via Active Demethylation in the Transition from Primed to Naive Pluripotency.
    Okashita N; Suwa Y; Nishimura O; Sakashita N; Kadota M; Nagamatsu G; Kawaguchi M; Kashida H; Nakajima A; Tachibana M; Seki Y
    Stem Cell Reports; 2016 Dec; 7(6):1072-1086. PubMed ID: 27866876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells.
    Adamo A; Sesé B; Boue S; Castaño J; Paramonov I; Barrero MJ; Izpisua Belmonte JC
    Nat Cell Biol; 2011 Jun; 13(6):652-9. PubMed ID: 21602794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanog, Oct4 and Tet1 interplay in establishing pluripotency.
    Olariu V; Lövkvist C; Sneppen K
    Sci Rep; 2016 May; 6():25438. PubMed ID: 27146218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reptin regulates pluripotency of embryonic stem cells and somatic cell reprogramming through Oct4-dependent mechanism.
    Do EK; Cheon HC; Jang IH; Choi EJ; Heo SC; Kang KT; Bae KH; Cho YS; Seo JK; Yoon JH; Lee TG; Kim JH
    Stem Cells; 2014 Dec; 32(12):3126-36. PubMed ID: 25185564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Link between embryonic stem cell pluripotency and homologous allelic pairing of Oct4 loci.
    Asaka MN; Uranishi K; Suzuki A; Hirasaki M; Nishimoto M; Okuda A
    Dev Growth Differ; 2017 Oct; 59(8):639-647. PubMed ID: 28967672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysine-specific histone demethylase 1 inhibition promotes reprogramming by facilitating the expression of exogenous transcriptional factors and metabolic switch.
    Sun H; Liang L; Li Y; Feng C; Li L; Zhang Y; He S; Pei D; Guo Y; Zheng H
    Sci Rep; 2016 Aug; 6():30903. PubMed ID: 27481483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylation of the Oct4A enhancers in embryonal carcinoma cells after etoposide treatment is associated with alternative splicing and altered pluripotency in reversibly senescent cells.
    Baryshev M; Inashkina I; Salmina K; Huna A; Jackson TR; Erenpreisa J
    Cell Cycle; 2018; 17(3):362-366. PubMed ID: 29372665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oct4 interaction with Hmgb2 regulates Akt signaling and pluripotency.
    Campbell PA; Rudnicki MA
    Stem Cells; 2013 Jun; 31(6):1107-20. PubMed ID: 23495099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maintenance of active chromatin states by HMGN2 is required for stem cell identity in a pluripotent stem cell model.
    Garza-Manero S; Sindi AAA; Mohan G; Rehbini O; Jeantet VHM; Bailo M; Latif FA; West MP; Gurden R; Finlayson L; Svambaryte S; West AG; West KL
    Epigenetics Chromatin; 2019 Dec; 12(1):73. PubMed ID: 31831052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.
    He Y; Zhao Y; Wang L; Bohrer LR; Pan Y; Wang L; Huang H
    Oncogene; 2018 Jan; 37(4):534-543. PubMed ID: 28991226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New histone demethylase LSD1 inhibitor selectively targets teratocarcinoma and embryonic carcinoma cells.
    Hoang N; Zhang X; Zhang C; Vo V; Leng F; Saxena L; Yin F; Lu F; Zheng G; Bhowmik P; Zhang H
    Bioorg Med Chem; 2018 May; 26(8):1523-1537. PubMed ID: 29439916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic control of transcriptional regulation in pluripotency and early differentiation.
    Gökbuget D; Blelloch R
    Development; 2019 Sep; 146(19):. PubMed ID: 31554624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LSD1: Expanding Functions in Stem Cells and Differentiation.
    Martinez-Gamero C; Malla S; Aguilo F
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analyzing bovine OCT4 and NANOG enhancer activity in pluripotent stem cells using fluorescent protein reporters.
    Huang D; Wang L; Talbot NC; Huang C; Pu L; Zhao X; Tian X; Zhang M; Tang Y
    PLoS One; 2018; 13(10):e0203923. PubMed ID: 30289916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.